Anti-Infectives & API
Business to Partners – Setting Standards
The Sandoz Anti-Infectives & API Business Unit is a fully-integrated provider of affordable, high-quality pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and finished dosage forms.
From our global headquarters in Kundl, Austria, we ensure excellence in manufacturing across our 10+ state-of-the-art production facilities and on-time delivery to our global network of industrial customers and partners. Production is carried out in accordance with current Good Manufacturing Practices (cGMP) and our facilities have been approved by all major health authorities worldwide, including the European Directorate for the Quality of Medicines (EDQM) and the United States Food and Drug Administration (FDA).
Our strong European production base, close cooperation with Novartis and decades of experience in pharmaceutical development, production and commercialisation, make it possible for us to set the industry standards for quality and continuity of supply.
Related content
Pioneering Biosimilars
Sandoz is the pioneer and undisputed global leader in the rapidly emerging market for biosimilars.
